Historical shareholding details of iShares Micro-Cap ETF holdings in Relmada Therapeutics Inc (RLMD)

Monthly changes of iShares Micro-Cap ETF shareholding in Relmada Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Micro-Cap Etf 54,208 0.18%
Feb 27, 2025 Ishares Micro-Cap Etf 54,208 0.18%
Feb 26, 2025 Ishares Micro-Cap Etf 54,208 0.18%
Jan 31, 2025 Ishares Micro-Cap Etf 56,088 0.19%
Jan 29, 2025 Ishares Micro-Cap Etf 56,088 0.19%
Dec 31, 2024 Ishares Micro-Cap Etf 55,336 0.18%
Dec 30, 2024 Ishares Micro-Cap Etf 55,336 0.18%
Nov 30, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Nov 27, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Oct 31, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Oct 30, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Oct 29, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Sep 30, 2024 Ishares Micro-Cap Etf 54,960 0.18%
Sep 27, 2024 Ishares Micro-Cap Etf 54,960 0.18%
Sep 25, 2024 Ishares Micro-Cap Etf 54,960 0.18%
Aug 30, 2024 Ishares Micro-Cap Etf 55,336 0.18%
Aug 29, 2024 Ishares Micro-Cap Etf 55,336 0.18%
Aug 28, 2024 Ishares Micro-Cap Etf 55,336 0.18%
Jul 31, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Jul 29, 2024 Ishares Micro-Cap Etf 54,584 0.18%
Jun 28, 2024 Ishares Micro-Cap Etf 52,704 0.17%
Jun 13, 2024 Ishares Micro-Cap Etf 53,080 0.18%
May 29, 2024 Ishares Micro-Cap Etf 54,960 0.18%
Apr 26, 2024 Ishares Micro-Cap Etf 56,088 0.19%
Mar 28, 2024 Ishares Micro-Cap Etf 57,216 0.19%
Mar 26, 2024 Ishares Micro-Cap Etf 55,233 0.18%
Feb 29, 2024 Ishares Micro-Cap Etf 57,561 0.19%
Feb 28, 2024 Ishares Micro-Cap Etf 57,561 0.19%
Jan 29, 2024 Ishares Micro-Cap Etf 56,618 0.19%
Dec 27, 2023 Ishares Micro-Cap Etf 56,618 0.19%
Nov 29, 2023 Ishares Micro-Cap Etf 56,387 0.19%
Oct 30, 2023 Ishares Micro-Cap Etf 56,023 0.19%
Sep 27, 2023 Ishares Micro-Cap Etf 57,479 0.19%
Aug 29, 2023 Ishares Micro-Cap Etf 57,843 0.19%
Jul 28, 2023 Ishares Micro-Cap Etf 58,571 0.19%
Jun 21, 2023 Ishares Micro-Cap Etf 60,391 0.20%
May 30, 2023 Ishares Micro-Cap Etf 57,893 0.19%

View all ownership details of Relmada Therapeutics Inc